Stock Events

Stock Events

Aerovate Therapeutics (AVTE) Q3 2024 Earnings

12AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.86

-0.8

-0.74

-0.68

Details

Expected EPS

-0.82236

Actual EPS

-0.86

Surprise EPS

-0.04

Surprise Percent

+4.58%

Description

Aerovate Therapeutics (AVTE) has reported earnings of -0.86 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.